Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-063485
Filing Date
2014-10-16
Accepted
2014-10-16 14:10:48
Documents
1
Period of Report
2014-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3126
  Complete submission text file 0001209191-14-063485.txt   4630
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 141159440